Jazz Pharmaceuticals Director Ted W. Love Files Form 144 to Sell $373K in Stock
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Filing Alert: Jazz Pharmaceuticals plc • Insider: Ted W. Love (Director) • Proposed Sale: 1,527 Common shares • Estimated Market Value: $373,413.00 (~$244.54/share) • Broker: E*TRADE Financial Corporation • Acquisition Source: Restricted Stock Vesting (Acquired 08/28/2026) • Approx. Sale Date: 08/31/2026
Comprehensive Analysis
Insider Filing Analysis: Form 144 Notice of Proposed Sale
Issuer: Jazz Pharmaceuticals plc (CIK: 0001232524)
Insider: Ted W. Love, Director (CIK: 0001188919)
Filing Date: August 31, 2026
Filing Accession: 0001188919-26-000013
Transaction Summary
- Securities Proposed for Sale: 1,527 Common Shares
- Aggregate Market Value: $373,413.00
- Implied Price per Share: ~$244.54
- Approximate Sale Date: August 31, 2026
- Broker: E*TRADE Financial Corporation
- Shares Outstanding: 64,914,577
Origin of Shares
- Date Acquired: August 28, 2026
- Nature of Acquisition: Restricted Stock Vesting (Equity Compensation)
- Securities Acquired: 1,527 shares
Significance & Market Impact
- Significance Rating: Low
- Context: The proposed sale represents a small transaction size ($373.4K) and corresponds directly to shares acquired via a recent restricted stock vesting on August 28, 2026. This type of transaction is common for board members liquidating equity compensation upon vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.